Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2021 Sep 8;5:100276. doi: 10.1016/j.envc.2021.100276

Conceptualizing a novel Hybrid Decontamination System (HDS) based on UV/H2O2 treatment for the enhanced decontamination and reuse of N95 FFRs

Shalini Anand a,, Divya Mahajan b, Sampriti Kataki c, Soumya Chatterjee d, Pankaj Kumar Sharma e, Pramod Kumar Rai f, Rajiv Narang g
PMCID: PMC8423981  PMID: 38620736

Abstract

The ongoing Pandemic of COVID-19 caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has severely stressed the worldwide healthcare system and has created dangerous shortages of personal protective equipment (PPE) including N95 filtering facepiece respirators (FFRs). Even though suppliers struggled to meet global demand for N95 masks at an unprecedented level, a shortage of FFR appears as a significant factor in the transmission of the disease to frontline workers. CDC, USA has mentioned that FFR decontamination and reuse may be necessary during times of shortage to ensure guaranteed availability. Hence present stressed condition faced by the healthcare sector seeks for an affordable decontamination strategy that can be replicated easily broadening the utility of FFR decontamination across a range of healthcare settings. After reviewing available literature on the various disinfection techniques that may be used for the decontamination of FFRs, a first of its kind, portable Hybrid Decontamination System/procedure has been conceptualized and designed. This system combines the disinfecting properties of both vaporous hydrogen peroxide (VHP) and ultra-violet C irradiation (UV C) to ensure maximum decontamination of N95 respirators. The instrument will be equipped with a hydrogen peroxide chamber and UV light source. Sterilization of the FFRs will be done through treatment with VHP followed by UV light treatment. The proposed system will allow the user to completely sterilize the FFRs in a time-efficient manner.

Keywords: Hybrid decontamination system, Vaporous hydrogen peroxide, Ultra-violet germicidal irradiation, Filtering facepiece respirators, Disinfection, COVID -19

Graphical abstract

Image, graphical abstract

Introduction

The spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) across the globe has led to an increase in the demand for filtering facepiece respirators (FFRs). Filtering facepieces are air-purifying particulate respirators working at negative pressure (ECRI, 2020). The usage of FFRs offers a non-pharmacological way of averting or slowing the spread of infectious diseases. FFRs are tightly fitted devices worn by healthcare professionals, infected persons, or the general public to lessen the spread of pathogens contained in aerosolized body fluids of the potentially infected persons, to other individuals. FFRs effectively filter out 95% solid and liquid aerosols (NPPTL-CDC, 2020). National Institute for Occupational Safety and Health (NIOSH), USA approved filtering facepiece respirator for use during the ongoing COVID-19 pandemic. A NIOSH-approved N95 respirator creates a seal against the user's face, eliminating the intrusion of contaminants along the edges. The filter has been listed in NIOSH Certified Equipment List (CEL) indicating its capacity to defend against at least 95% of airborne contaminants (CDC, 2020a, 2020b; Bergman et al., 2010). The mask must be double strapped and clearly labeled with both a letter designation (N, R, P) indicating the capacity of the mask's filtering efficiency (in percentage) in presence of oil (NPPTL-CDC, 2020). It is recommended to use N when zero oil is existing in the air; R, when oil is present but only for one slot or 8 h of uninterrupted or intermittent use and P when oil is present but manufacturer's time use restrictions to be followed if reuse to be done respectively (Table 1 ). The filter consists of thousands of synthetic woven fibers combined with a melt-blown extrusion process treated to sustain an electrostatic charge (i.e., an electret). In addition to providing a mechanical shield against aerosols; N95 filters filter out charged particles including microbes, though it provides little protection against gases, oils, or vapors (ECRI, 2020).

Table 1.

FFRs types and their filtering percentage.

Respirator (FFRs) types Filtering percentage of airborne particles (at least) Resistant to oil
N95 95% No
N99 99% No
N100 99.97% No
R95 95% Somewhat
P95 95% Strongly
P99 99% Strongly
P100 99.97% Strongly

Source: NIOSH approved FFRs (NPPTL-CDC, 2020).

The current COVID19 pandemic triggered by SARS-CoV-2 has severely strained the global healthcare environment and generated a scarcity of personal protective equipment (PPE) worldwide. Though the FFRs such as N95 have been designed for single-use, the worldwide increase in demand has caused shortages in their supply (Nogee and Tomassoni, 2020; Wu et al., 2020). As it was expected in evolving respiratory pandemics, demand for N95 FFR has far surpassed their manufacturing capacity (Rodriguez-Martinez et al., 2020). Health care workers have no alternative in many countries but have to use low-level PPE and breathing devices (CDC 2020c; OSHA (Occupational Safety and Health Administration), 2020). A shortage of PPE is a significant factor in the transmission of the disease to frontline workers participating in the diagnosis, testing, and treatment of infected persons (Chughtai et al., 2020). The U.S. Centers for Disease Control and Prevention does not recommend N95 FFP respirators for general public use, stating that they should be reserved for healthcare workers (Srinivasan and Peh, 2020). When global demand for N95 masks grew by 2020 at an unprecedented level due to the pandemic, suppliers struggled to raise production to satisfy the demand. It has been reported that N95 masks which had a market valuation of over US$ 802 million in 2019, by 2027, this value is expected to rise more than double to approximately US$ 1.90 billion (Garside, 2020).

Hence to satisfy the rocket high demand of N95 FFR, wearing an N95 respirator for extended hours or reusing a respirator several times are suggested practices to ease shortages. One of the proposed strategies for mitigating the massive demand for N95 FFRs is their reuse after appropriate decontamination that allows the inactivation of any potentially infectious material attached to the surfaces (Rodriguez-Martinez et al., 2020). While single-use N95s FFRs are not approved for routine decontamination as standard practice, CDC, USA has mentioned that FFR decontamination and reuse may be necessary during times of shortage to ensure guaranteed availability (CDC, 2020a). Food Drug Association (FDA) issued an Emergency Use Authorization (EUA) on March 28, 2020, for the Battelle Critical Care Decontamination System (CCDS) to decontaminate compatible N95 respirators during the COVID19 public health emergency. In light of this, strategies revolving around the extended use and reuse of FFRs have surfaced, based on a safe, easy, and accessible sterilization solution. Complete decontamination recycling strategy of respirators is based on the following four key aspects: inactivation of the intended organism, no damage on the respirator's filtration; no change in the shape of the respirator; and safety of the individual wearing the respirator is not compromised. Therefore, it is imperative to devise efficient disinfection techniques which will retain the filtration performance and fit of the FFRs while at the same time inactivate all biological contaminants. The disinfection method must be time and cost-effective as well as easy to operate. The most promising results so far to treat FFRs were demonstrated by physical and chemical decontamination methods viz. ultraviolet germicidal irradiation, steam sterilization, ethylene oxide, and vapor hydrogen (Polkinghorne and Branley, 2020).

The need for abundant, complete, reliable respiratory defense is fostering research, as the current pandemic is anticipated to continue for months and the risk of potential airborne biological threats remains. The present condition faced by the healthcare sector related to the availability of quality FFRs and its reusability seeks for appropriate decontamination strategy that can be replicated easily broadening the utility of FFR decontamination across a range of healthcare settings. Based upon this background, the present paper discusses the advantages and limitations of the available disinfection technologies being practiced for FFR decontamination to identify appropriate disinfection measures with the most effective result as well as the least hazardous and environmental concern. Accordingly, a Hybrid Decontamination System (HDS) has been conceptualized based on vaporous hydrogen peroxide (VHP) and ultra-violet irradiation (UV C) to ensure the complete decontamination of FFRs and to prevent PPE shortages in the future while facing the spread of an infectious disease. It is expected that such decontamination strategies of HDS would be very much relevant to ease out the shortage of FER and may be implemented by health care facilities at the time of crisis.

Current disinfection techniques

Previous influenza outbreaks (SARS-CoV, MERS-CoV, H1N1, etc.) and the ongoing SARS-CoV-2 pandemic have caused researchers to focus on the decontamination and reuse of FFRs in emergencies. Various organizations have proposed the reuse of N95 FFRs after the respirator has been thoroughly decontaminated (CDC, 2020a, 2020c). However, improper decontaminated respirators may create more problem by exposing the person wearing it to the pathogens in the FFR (CDC, 2020a). In addition, for the FFR to be effective in blocking the transmission of pathogens, its filtration performance and fit must not be compromised during the decontamination procedure In general, an ideal decontamination process should be easy to operate and should not cause any damage to the material, appearance and fitting aspects of the FFR. Further, ideal disinfection should disinfect a broad spectrum of biological agents from all parts of FFRs, should not leave any hazardous residue, should retain optimum filtration efficiency following treatment (Fig. 1 ). Therefore, it is imperative to choose a disinfection technology that not only decontaminates the respirator but also does not damage its fit and filtration performance. Various research groups have evaluated the FFR quality after decontamination with different disinfectants (Table 2 ). Many of these approaches can be undertaken in existing available equipment for FFR decontamination or may be repurposed to maintain necessary product conditions.

Fig. 1.

Fig. 1

The requirements for an ideal FFR decontamination strategy.

Table 2.

Disinfection techniques.

S.No Disinfection technique Mode of action Advantages Disadvantages FFR quality check after disinfection Reference
1 Vaporous Hydrogen Peroxide (VHP) Produces hydroxyl radicals which can destroy proteins, nucleic acids and lipid membranes
  • Fast germicide

  • Effective against a large set of micro organisms

Degassing (removal of H2O2 vapors) is time consuming.
  • Efficiency of filtration is retained after 10 cycles and the FFR fit is not affected up to 20 cycles

Battelle (2016), Viscusi et al. (2009), Schwartz et al., (2020), Torres et al. (2020)
2. H2O2 Gas Plasma
  • Filtration performance of the FFR is compromised after 3 cycles

Bergman et al. (2010)
3. UV C Destroys nucleic acids by creating photo-dimers
  • Inactivates pathogen at wavelengths between 240 - 280 nm.

  • Significant reductions (≥3 log) in influenza viability under different soiling conditions of FFR

  • Leaves no toxic residue

Ineffective for sterilization of tools with multiple curves due to shadow effects.
  • Filtration efficiency and fit are acceptable after 3 cycles

  • Difficulty in decontaminating FFR straps

Bergman et al. (2010), Viscusi et al. (2009), Lindsley et al. (2015), Torres et al. (2020), Lowe et al. (2020), Fisher et al. (2011), Lore et al. (2012), Viscusi et al. (2011), Mills et al. (2018)
Requires enclosed devices to protect users from exposure.
Require careful consideration of FFR model, material type, and design
4. Steam sterilization (microwave generated) High temperature denatures proteins and enzymes.
  • Non toxic and inexpensive

  • Used for sterilization of equipments which are heat and moisture resistant

  • Can fully penetrant to porous FFR surface

Material (fabric) may deteriorate
  • No change in filtration efficiency for up to 3 cycles

  • Little effect on FFR fit

  • High powered microwaves may degrade the filter material

Bergman et al. (2010), Fisher et al. (2011), Lore et al. (2012), Viscusi et al. (2011)
Steam sterilization (autoclave)
  • Might cause substantial filter degradation

  • May damage polymer fibers in the filter and compromise its performance

5. Ethylene oxide (EtO) gas Leads to alkylation which causes structural changes in proteins and nucleic acids
  • Can be used to disinfect equipment which are sensitive to heat and moisture.

  • Inactivates all types of microorganisms

  • Generally does not affect physical appearance, fitting and filter performance

Potential carcinogen EtO is not recommended as it is highly reactive, diffusible toxic gas and needs a long aeration time to be completely removed, Presence of residual gas
  • Does not affect filtration performance for up to 3 cycles.

  • 2-hydroxyethyl acetate residue was formed as a byproduct

Viscusi et al. (2009), Salter et al. (2010)
7. Chlorine and chlorine related compounds Mechanism of action not fully understood
  • Antimicrobial action against a vast array of microbes.

  • High biocidal efficacy

Unpleasant odor of bleach remains after disinfection. Chlorine off-gassing may also be observed.
  • No to moderate negative effect on filtration performance

  • Filtration efficiency is affected at high NaOCl concentrations

  • Corrosion of metal parts in FFR might be observed

Bergman et al. (2010), Viscusi et al. (2009), Lin et al. (2017), Salter et al. (2010)
8. Alcohol Denaturation of proteins
  • 60 - 80% ethanol can inactivate all lipophilic viruses.

Not recommended for disinfection of medical apparatus.
  • Causes degradation of filters

  • Might lead to decreased filtration performance and increased filter penetration

  • Severe degradation of electret filters due to alters the density and/or spatial distribution of the

  • Electret charges on the surface of polymer fibers

Lin et al. (2017)

Presently the suggested decontamination methods for FFRs are steam sterilization by microwave and autoclave, chlorine-based products, ethylene oxide, UV germicidal irradiation, H2O2 gas plasma, vaporized H2O2, soapy water decontamination. As shown in Table 2, chemical sterilization using soap and water, alcohols, and bleach is not the ideal strategy for FFR decontamination as they render the respirator nonfunctional many times. Steam sterilization by autoclave or microwave though are effective, and non-toxic (with no hazardous residual), but may damage polymer fibers in the filter compromising its performance (Su-Velez et al., 2020). Due to the strong viral inactivation efficiency and no disinfection or oxidation product production, vaporized hydrogen peroxide (VHP) cum UV irradiation appears to be viable options for successful decontamination. Fischer et al. (2020) showed that N95 respirators can be decontaminated and reused up to 3 times by using UV light and VHP and 1–2 times by using dry heat without compromising its quality.

As observed in Table 1, VHP, UV C, and microwave generated moist heat treatments are suitable for decontamination of FFRs. 3M a multinational company headquartered in the USA, the manufacturer of the popular 3M N95 FFRs, released a list of VHP, UV, and moist heat-related decontamination technologies for FFR disinfection (3M Technical Bulletin, 2021). Currently, VHP systems from Steris, STERRAD, Sterilucent, and Battelle have passed the filtration efficiency and fit evaluation test after 10, 2, 10, and 3 cycles, respectively. A frequent application of VHP is for terminal decontamination of hospital rooms, biosafety cabinets, and medical equipment and materials that are intolerant to heat or have diffusion-restricted space. This generally kills extremely challenging pathogens, including bacterial spores and viruses. Several studies have established that certain N95 respirators can be securely decontaminated with appropriate use of Integrated Vapor-Phase Hydrogen Peroxide- VPHP (Battelle, 2016, 2020; Bergman et al., 2010; Viscusi et al., 2009). Xenex Lightstrike System, which is based on UV disinfection, is relying on similar principal (Technical Bulletin, XENEX, 2021). A recent revision reported that ultraviolet germicidal irradiation and vaporized hydrogen peroxide appear to have the potential for decontamination of FFR (Fischer et al., 2020). Based on this data, along with the data in Table 2, we can identify that VHP cum UVC are potent disinfection techniques that will not compromise the filtration efficiency and fit of the FFR and applicable up to 10 cycles. However, Table 2 also indicates that both the decontamination methods are associated with some limitations. Hydrogen peroxide is toxic and the de-gassing time is long (Schwartz et al., 2020). UV C irradiation may not be adequate to produce the desired level of disinfection in the case of surfaces with multiple curves due to shadow effects (Lindsley et al., 2015). Varied authorizations for decontamination products changes with time and as per the requirement of public health emergency, and availability of comparable product; however, attempt to minimize the limitations, it is always better to be prepared for any airborne pandemic in future. We hereby present here a hybrid decontamination system (HDS) for the complete decontamination and reuse of FFRs.

Proposed Hybrid Decontamination System (HDS)

Based on this background present work aims to develop a multi-chambered treatment unit with provision for multiple disinfection barriers appropriate for decontamination of N95 FFR for reuse. In present times, the use of multiple disinfection barriers is receiving international attention to ensure and maximize the efficiency of conventional disinfectants. As a report on the removal of SARS-CoV-2 by current conventional decontamination strategies is at the experimental stage, it is imperative to take extra precaution by combining different compatible disinfection strategies to ensure complete eradication of the viruses from any surface (Venugopal et al., 2020). A system with multiple disinfection steps might provide synergistic benefits, enhanced reliability, robustness, and flexibility for decontamination.

Adequate evidence is indicative that the novel coronavirus 2 is one of the uncomplicated viruses to be deactivated. The genome of the SARS-CoV-2 virus is phylogenetically very comparable to bat SARS-associated coronaviruses (84% nucleotide similarity with bat-SL-CoVZC45 coronavirus), and the spike protein has a 78% nucleotide similarity with the human SARS-CoV-1 virus (Chan et al., 2020). Therefore, SARS-CoV-2 is expected to be prone to environmental causes or disinfectants applied during previous SARS outbreaks (Wang et al., 2020). Maris (1990) in their work on coronavirus stated that the existence of envelope in coronaviruses render them vulnerable to microbicides as opposed to non-enveloped. The recent analysis predicts that conventional disinfectant procedures should be successful to kill or inactivate the virus (Kataki et al., 2021). US EPA has released a list of 402 disinfectants that can be used against the SARS CoV 2 pathogen (US EPA, 2020).

It has been shown that the combination of hydrogen peroxide and UV irradiation leads to a powerful decontamination system and this combination has been increasingly used for wastewater disinfection (Bayliss and Waites, 1979; Sun et al., 2016; Collivignarelli et al., 2018; Galvis et al., 2018). Bounty et al. (2012) reported a 4 log reduction of adenovirus at a UV dose of about 200 mJ cm−2 and an addition of 10 mg l−1 H2O2 to the process could help achieve 4 log inactivation at a lower UV dose of 120 mJ cm−2. When used in conjunction, they create an environment rich in reactive oxygen species (ROS) which are potent in eliminating biological contaminants. In this regard, an automated, hands-free, system has been conceptualized and designed for the complete and thorough disinfection of N95 FFRs. This system relies on the decontamination properties of VHP and UV C while reducing the restrictions faced when they are used individually (Fig. 2 ).

Fig. 2.

Fig. 2

Pictorial representation of proposed Hybrid Decontamination System.

Hybrid Decontamination System-working details

As shown in Fig. 2, the decontamination system has been designed to be compact and is divided into two chambers: vaporization chamber and sterilization chamber. A circular rotating tray is equipped with a rack that allows the FFRs to be held in place. The tray rotates while sterilization is occurring to ensure that all FFRs are evenly exposed to VHP and receive the same intensity of UV C irradiation. The proposed decontamination process has been illustrated in Fig. 3 .

Fig. 3.

Fig. 3

Proposed protocol for decontamination of FFRs using Hybrid Decontamination System.

H2O2 treatment

Once, the FFRs have been placed on the circular rotating rack, they enter into the sterilization chamber. This is followed by the release of VHP from the vaporization chamber (Fig. 3). VHP enters the sterilization chamber till a concentration of 480 ppm is reached. For detection of H2O2 level inside the chamber, a H2O2 sensor is placed inside the sterilization chamber.

A study conducted by Schwartz et al. (2020) demonstrates the use of VHP (480+ ppm) to decontaminate N95 FFRs. In another recent study, Grossman et al. (2020) suggest a concentration of 700 ppm for disinfection. As our proposed system is equipped with two disinfection technologies, we suggest the use of 480 ppm for the disinfection of N95 FFRs. The VHP treatment will consist of two main steps:

  • a.

    Gassing Phase: Hydrogen peroxide vapors will be created in a container by heating the liquid H2O2 solution (35 %). H2O2 has a low vapor pressure of 5 mm Hg at 30°C, therefore, a temperature range of 50-60°C should be adequate for H2O2 to vaporize. Vaporous H2O2 will then diffuse throughout the sterilization chamber and the H2O2 vapors container. The vapors will create a biocidal environment that initiates the deactivation of microorganisms by chemical interactions at multiple biologically important reaction sites. Assuming that the rate of release of H2O2 vapors will be 2g min−1 for a volume of 88.5 L cabinet, the gassing phase will take roughly 30 min. Total gassing time can be affected by the rate of release of vapors and the volume of the chamber.

  • b.

    Gassing Dwell: This is the time allowed for H2O2 vapors to penetrate and decontaminate all layers/ parts of the FFR. During this time, H2O2 vapors will be released at a low rate to maintain the minimum concentration of 480 ppm. Current practices involving decontamination through H2O2 vapors allow the FFRs to be in contact with H2O2 for 20 min after the gassing phase (Schwartz et al., 2020; Battelle, 2016). This will allow enough time for the H2O2 to interact with the microorganisms and to completely inactivate it. A lesser time may allow the H2O2 to damage, but may not be able to completely eradicate the microorganism, which is not ideal. Thus, the maximum time taken for H2O2 treatment is proposed to be approximately 50 min. In addition, a lid will be provided on top of the container to add more peroxide solution.

UV C treatment

After treatment with H2O2 vapors, the FFRs will be exposed to UV C light for at least 15 min. Studies have also demonstrated that a UV dose of 2-5 mJ cm−2 is effective in eliminating single-stranded RNA viruses, such as SARS-CoV-2 (Tseng and Li, 2007). Consequently, we propose a UV C dose of 300 mJ cm−2 against the usage of as high as 950 J cm−2 (Lindsley et al., 2015) which will be effective in inactivating not only the SARS-CoV-2 but will also assist in the inactivation of other biological contaminants. In accordance with this dose, UV lamps may be selected keeping the exposure time of 15 min.

Aeration

After UV C treatment, fresh air will be circulated inside the sterilization chamber to convert all residual H2O2, if any, into water and oxygen. This process is de-gassing and will occur until the concentration of H2O2 inside the chamber is below detectable levels.

The efficiency of conceptualized Hybrid Decontamination System

The efficiency of sterilization via treatment with H2O2 vapors and UV C irradiation individually is well recorded in the literature. Fig. 4 displays the mechanism of action of H2O2 and UV C light against microorganisms. H2O2 decomposes into reactive oxygen species (hydroxyl radicals, OH and superoxide ions, O2 ) which attack important biomolecules that create cellular/viral structure and function (Linley et al., 2012). Moreover, the superoxide ion may combine with nitric oxide (NO) (in vivo) to form the peroxynitrite ion which can lead to lipid peroxidation, protein oxidation and inactivation of microbial enzymes (Hogg et al., 2017, Trujillo et al., 2010). Studies have suggested that the VHP displays a better ability to degrade protein structure (Fichet et al., 2007). The primary virucidal mechanism of H2O2 is excessive disruption to viral nucleic acids, lipids, and other cells components by OH-radicals for which virus do not bear any repair mechanism (McDonnell, 2009). UV C mainly inactivates the microorganism by disrupting nucleic acids. This occurs because UV C light causes pyrimidine-type molecules (in RNA and DNA) to dimerize which causes distortions in nucleic acid molecules, ultimately leading to cell/virus death (Chang et al., 1985). UV C irradiation will also convert the remaining H2O2 into radical species, further leading to the elimination of viable microorganisms. The detailed schematic representation on FFR treatment is presented in Fig. 4.

Fig. 4.

Fig. 4

Detailed mechanism for decontamination strategies (Step 1 VHP treatment and Step 2 UV-C treatment).

H2O2 is a safer, healthier oxidizing option typically available at a concentration of 35% which is effective against a range of bacteria, fungi, yeasts, viruses, and spores. Exposure of H2O2 vapor (20 μl) to a coronavirus surrogate TGEV on stainless steel for 2–3 h was observed to result in roughly a drop of 5 log10 (TCID 50 ml−1) as per the study reported by Goyal et al. (2014). Various studies have suggested that VHP (dry or wet) is effective in decontaminating FFR (Bergman et al., 2010; Battelle, 2016, 2020; Viscusi et al., 2009; Schwartz et al., 2020; Torres et al., 2020). Duke University Hospitals are currently using VHP at a concentration of 300-750ppm to decontaminate FFRs (Schwartz et al., 2020). In addition, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) to Advanced Sterilization Products (ASP) for the STERRAD Sterilization Cycles (STERRAD 100S Cycle, STERRAD NX Standard Cycle, or STERRAD 100NX Express Cycle), which uses VHP gas plasma sterilization (Battelle, 2020).

The sterilization effects of UV C light have also been extensively studied. It has been shown that UV C light was successful in inactivating the SARS-CoV (Duan et al., 2003; Darnell et al., 2004). Duan et al. (2003) (45] found that 60 min of UV irradiance is enough to kill viral infectivity at undetectable amounts using a SARS coronavirus strain CoV-P9. Susceptibility of mouse canine coronavirus, hepatitis virus, Kilham rat virus, and canine parvovirus towards UV irradiation was shown by Saknimit et al. (1988). A UV exposure, particularly UV-C, (254 nm, 4016 μW cm−2 dose), as shown by Darnell et al. (2004), is effective in a 400-fold decrease in infectious virus at 1 min of exposure, which subsequently became fully inactivated after 15 min of exposure. Due to the similarity between the structure of SARS-CoV and SARS-CoV-2 (Zhou et al., 2020), it can be assumed that the latter will also be highly susceptible to UV light (Kowalski et al., 2020). Additionally, a report published in Nebraska Medicine outlined the decontamination process of N 95 FFRs via UVGI. Currently, the University of Nebraska Medical Center uses UVGI to sterilize N95 FFRs in 15 min (Lowe et al., 2020).

Moreover, upon application of UV C, the residual H2O2 will be converted to hydroxyl radicals which will further inactivate the microorganism. The dual action of hydroxyl radicals and UV C will ensure that all biological contaminants are eradicated. Thus, the sterilization process will become more efficient. Owing to the large amount of evidence supporting the individual sterilization properties of H2O2 vapors and UV C light, we can safely say that the proposed system will also be effective in the decontamination of FFRs and will provide maximum sanitization.

Advantages of proposed HDS over single system methods of decontamination

Simply using UV C to decontaminate respirators will not be effective as the FFRs have layers and the UV C may not be able to completely decontaminate all layers. The Centers for Disease Control and Prevention has suggested that UV C irradiation may not inactivate all biological contaminants on an FFR due to shadow effects produced by the multiple layers of the FFR's construction (Lindsley et al., 2015). Therefore, solely relying on UV C treatment may not offer maximum decontamination.

The use of VHP also has some disadvantages. In systems involving decontamination through VHP, after treatment with H2O2 gas, the chamber has to be filled with fresh air to decompose all residual H2O2 into H2O and O2. This process is called de-gassing and it is very time-consuming. The chamber is usually safe to enter only after 4 h, which makes the overall VHP based decontamination process not a very time efficient one (Schwartz et al., 2020). Thus, in the proposed dual system, using UV C light following VHP treatment will achieve two purposes viz. i. inactivation of all remaining biological contaminants and ii. conversion of residual H2O2(g) into water and oxygen xeand reduce the overall time of decontamination. Being sensitive, H2O2breaks down to produce radical species in presence of light. In absence of any other chemicals, these radicals recombine to form stable products, in this case, water and oxygen (https://www.rsc.org/Education/Teachers/Resources/Contemporary/student/pop_peroxide.html). Short wavelength UV light catalyzes the process that reduces overall de-gassing time. This will allow the user to observe maximum sanitization while the process remains time efficient.

Effectiveness of FFRs post sterilization

Reports have shown that the sterilization technology equipped with vaporous H2O2 and UVGI will not impair the FFR filtration performance and fit of the FFR (Table 2). When used individually, UV-C rays as high as 950 J cm−2 efficiently sterilize the FFRs without damaging its filtration performance and fitting to the user (Lindsley et al., 2015; Liao et al., 2020). This system utilizes a UV dose of 300 mJ cm−2 which is well below the dose required to alter the filtration performance of the respirator. Treatment using vaporous H2O2 alone does not damage the function of FFR up to 20 cycles. Therefore, we are aiming at least 10 cycles of complete decontamination of FFRs using the proposed device.

There will be no chemical residue post sterilization as fresh air will be circulated which will convert all remaining H2O2 into water and oxygen. The FFRs will be removed only when the H2O2 concentration is below detectable levels. It should, however, be noted that the proposed system has only been conceptualized and designed. Therefore, the FFR function must be checked after each sterilization cycle. The standard protocol for determining the efficiency level for N95 FFRs is provided by National Institute for Occupational Safety and Health (NIOSH) and the same procedure may be used to check the FFR filtration performance after sterilization (NIOSH, 2019) (NIOSH, 2020). The fit of the FFR must also be evaluated before the FFR is reused. A recent study on the aspect of the reusability and decontamination methods of N95 masks has been reviewed by Peters et al. (Peters et al., 2021). However, appropriate preparation on the technology development and related application is seems to be necessary, even for the future.

Conclusion

The lack of PPE is a major factor in the transmission of the pandemic COVID19 among the frontline staff engaged in testing, treating, and handling infectious people. One of the suggested solutions to minimize mass demand for N95 FFRs is to reuse them after sufficient decontamination, enabling any contagious surface to be inactivated along with not compromising FFR quality. While FFRs N95s are unapproved for routine decontamination as a normal practice, CDC, USA reported that FFR decontamination and reuse could be needed during scarcity to provide assured supply. Among the various suitable method suggested for FFR decontamination vaporous hydrogen peroxide (VHP) and UV C irradiation are effective methods for the decontamination of FFRs with no immediate health and environmental concern. It has been shown that these two methods do not hamper the filtration efficiency and the FFR fit for up to 10 cycles with VHP and 3 cycles with UV. However, there are limitations associated with both disinfection techniques when used individually. Therefore, we have conceptualized and proposed a Hybrid Decontamination System (HDS) which combines the advantages of both methods and minimizes the limitations. The proposed decontamination technique is time efficient and will ensure maximum decontamination of FFRs.

It is anticipated that in absence of appropriate manufacturer recommendations about FFR decontamination, facilities dealing with COVID19 cases may consider adopting and developing such strategies to minimize the shortage of N95s. Though it is expected that the proposed strategy would effectively decontaminate without impacting the respirator functionality and effectiveness; however, it is emphasized that the proposed system must be tested as per NIOSH standard protocol for the efficacy of the FFRs post sterilization.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Funding sources

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Ethics approval

This article does not contain any studies with human participants or animals performed by any of the authors

Consent for publication

This manuscript does not contain any data or image which is already published.

Acknowledgements

Authors would like to thank Professor Rahul Narang from Mahatma Gandhi Institute of Medical Sciences, Wardha, Maharashtra, Dr. Sukhvinder Singh from Max Super Specialty Hospital, Shalimar Bagh, and Dr Ashwini Ghai from NKS Hospital, Gulabibagh for giving their valuable comments during the preparation of manuscript. Authors gratefully acknowledge Director CFEES and Director, DRL DRDO for benevolent support and motivation.

References

  1. ECRI Safety of extended use and reuse of N95 respirators. Clin. Evid. Assess. 2020;March 2020:1–26. https://www.elsevier.com/data/assets/pdf_file/0006/997863/COVID-ECRI-N95-Respirators_2020-03.pdf ECRI. Available at: [Google Scholar]
  2. NPPTL-CDC, 2020. NIOSH-Approved Particulate Filtering Facepiece Respirators, April 9, 2020. Available at: https://www.cdc.gov/niosh/npptl/topics/respirators/disp_part/default.html.
  3. CDC. Decontamination and reuse of filtering facepiece respirators. 2020a. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/decontamination-reuse-respirators.html. [Accessed 27 September 2020].
  4. CDC. N95: myth V/S facts. 2020b. Available at: https://www.cdc.gov/niosh/npptl/pdfs/infographic-n-95-508.pdf.
  5. Bergman M.S., Viscusi D.J., Heimbuch B.K., Wander J.D., Sambol A.R., Shaffer R.E. Evaluation of multiple (3-Cycle) decontamination processing for filtering facepiece respirators. J. Eng. Fibers and Fabr. 2010;5:33–41. doi: 10.1177/155892501000500405. [DOI] [Google Scholar]
  6. Nogee D., Tomassoni A. Covid-19 and the N95 respirator shortage: closing the gap. Infect. Control Hosp. Epidemiol. 2020 doi: 10.1017/ice.2020.12418. PMCID: PMC7205548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Wu H., Huang J., Zhang C.J.P., He Z., Ming W.K. Facemask shortage and the novel coronavirus disease (COVID-19) outbreak: reflections on public health measures. EClinicalMedicine. 2020;21 doi: 10.1016/j.eclinm.2020.100329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Rodriguez-Martinez C.E., Sossa-Briceño M.P., Cortés-Luna JA. Decontamination and reuse of N95 filtering facemask respirators: a systematic review of the literature. Am. J. Infect. Control. 2020;48(12):1520–1532. doi: 10.1016/j.ajic.2020.07.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. CDC, 2020c. Implementing Filtering Facepiece Respirator (FFR) reuse, including reuse after decontamination, when there are known shortages of N95 respirators https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/decontamination-reuse-respirators.html (Accessed 27 September 2020)
  10. OSHA (Occupational Safety and Health Administration). 2020. Enforcement guidance on decontamination of filtering facepiece respirators in healthcare during the coronavirus disease 2019 (COVID-19) pandemic; [Accessed 2 April 2020]. https://www.osha.gov/memos/2020-04-24/enforcement-guidance-decontamination-filtering-facepiece-respirators-healthcare.
  11. Chughtai A.A., Seale H., Islam M.S., Owais M., Macintyre C.R. Policies on the use of respiratory protection for hospital health workers to protect from coronavirus disease (COVID-19) Int. J. Nurs. Stud. 2020;105 doi: 10.1016/j.ijnurstu.2020.103567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Srinivasan S., Peh W.C.G. N95 filtering facepiece respirators during the COVID-19 pandemic: basics, types, and shortage solutions. Malays. Orthop. J. 2020;14(2):16–22. doi: 10.5704/MOJ.2007.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. M. Garside, (2020), N95 mask market value worldwide 2019 & 2027. Available at: https://www.statista.com/statistics/1148474/global-n95-mask-market-size/.
  14. Polkinghorne A., Branley J. Evidence for decontamination of single-use filtering facepiece respirators. J. Hosp. Infect. 2020 doi: 10.1016/j.jhin.2020.05.032. PMID: 32473179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Su-Velez B.M., Maxim T., Long J.L., St John M.A., Holliday M.A. Decontamination methods for reuse of filtering Facepiece respirators. JAMA Otolaryngol. Head Neck Surg. 2020;146(8):734–740. doi: 10.1001/jamaoto.2020.1423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Fischer R.J., Morris D.H., Van Doremalen N., Sarchette S., Matson M.J., Bushmaker T., Yinda C.K., Seifert S.N., Gamble A., Williamson B.N., Judson J.D. Effectiveness of N95 respirator decontamination and reuse against SARS-CoV-2 virus. Emerg. Infect. Dis. 2020;26(9):2253. doi: 10.3201/eid2609.201524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. 3M Technical Bulletin. Decontamination of 3M filtering facepiece respirators, such as N95 respirators, in the United States-Considerations, July, 2021 (revision 15). Available at: https://multimedia.3m.com/mws/media/1824869O/decontamination-methods-for-3m-filtering-facepiece-respirators-technical-bulletin.pdf (Accessed 21 Aug 2021 )
  18. Battelle. July 2016. Final report for the bioquell H2O2 Vapor (HPV) Decontamination for Reuse of N95 Respirators. Prepared by Battelle Columbus, Ohio. Prepared under Contract No. HHSF223201400098C. Study Number 3245. Prepared for the FDA.
  19. Battelle. Decontamination system gets EUA to fight respirator shortage, https://medtech.pharmaintelligence.informa.com/MT126497/Battelle-Decontamination-System-Gets-EUA-To-Fight-Respirator-Shortage. [Accessed on 30 August 2020 ].
  20. Viscusi D.J., Bergman M.S., Eimer B.C., Shaffer R.E. Evaluation of five decontamination methods for filtering facepiece respirators. Ann. Occup. Hyg. 2009;53(8):815–827. doi: 10.1093/annhyg/mep070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Technical Bulletin, XENEX, Germ zapping solution; 2021 https://xenex.com/
  22. Schwartz A., Stiegell M., Greeson N., Vogel A., Thomann W., Brown M., Sempowski G.D., Alderman T.S., Condreay J.P., Burch J., Wolfe C., Smith B., Lewis S. Decontamination and reuse of N95 respirators with hydrogen peroxide vapor to address worldwide personal protective equipment shortages during the SARS-CoV-2 (COVID-19) pandemic. Appl. Biosaf. J. ABSA Int. 2020;25(2):67–70. doi: 10.1177/1535676020919932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lindsley W.G., Martin Jr S.B., Thewlis R.E., Sarkisian K., Nwoko J.O., Mead K.R., Noti J.D. Effects of ultraviolet germicidal irradiation (UVGI) on N95 respirator filtration performance and structural integrity. J. Occup. Environ. Hyg. 2015;12(8):509–517. doi: 10.1080/15459624.2015.1018518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Venugopal A., Ganesan H., Raja S.S.S., Govindasamy V., Arunachalam M., Narayanasamy A., Sivaprakash P., Rahman P.K., Gopalakrishnan A.V., Siama Z., Vellingiri B. Novel wastewater surveillance strategy for early detection of COVID–19 hotspots. Curr. Opin. Environ. Sci. Health. 2020;17:8–13. doi: 10.1016/j.coesh.2020.05.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Chan J.F.W., Yuan S., Kok K.H., To K.K.W., Chu H., Yang J., Xing F., Liu J., Yip C.C.Y., Poon R.W.S., Tsoi H.W. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–523. doi: 10.1016/S0140-6736(20)30154-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wang J., Shen J., Ye D., Yan X., Zhang Y., Yang W., Li X., Wang J., Zhang L., Pan L. Disinfection technology of hospital wastes and wastewater: suggestions for disinfection strategy during coronavirus disease 2019 (COVID-19) pandemic in China. Environ. Pollut. 2020 doi: 10.1016/j.envpol.2020.114665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Maris P. Virucidal efficacy of eight disinfectants against pneumovirus, coronavirus and parvovirus. Ann. Rech. Vet. 1990;21(4):275–279. [PubMed] [Google Scholar]
  28. Kataki S., Chatterjee S., Vairale M., Sharma S., Dwivedi S.K. Concerns and strategies for wastewater treatment during COVID-19 pandemic to stop plausible transmission. Resour. Conserv. Recycl. 2021;164 doi: 10.1016/j.resconrec.2020.105156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. US EPA. List N: disinfectants for Use against SARS-CoV. 2020. Available at: https://www.epa.gov/pesticide-registration/list-n-disinfectants-use-against-sars-cov-2.
  30. Bayliss C.E., Waites W.M. The combined effect of hydrogen peroxide and ultraviolet irradiation on bacterial spores. J. Appl. Bacteriol. 1979;47:263–269. doi: 10.1111/j.1365-2672.1979.tb01753.x. [DOI] [PubMed] [Google Scholar]
  31. Sun P., Tyree C., Huang C.H. Inactivation of Escherichia coli, bacteriophage MS2, and Bacillus spores under UV/H2O2 and UV/Peroxydisulfate advanced disinfection conditions. Environ. Sci. Technol. 2016;50(8):4448–4458. doi: 10.1021/acs.est.5b06097. [DOI] [PubMed] [Google Scholar]
  32. Collivignarelli M.C., Abba A., Benigna I., Sorlini S., Torretta V. Overview of the main disinfection processes for wastewater and drinking water treatment plants. Sustainability. 2018;(86):10. doi: 10.3390/su10010086. [DOI] [Google Scholar]
  33. Galvis E.A.S., Ospina L.S., Jiménez J.N., Pino N.J., Palma R.A.T. Elimination of carbapenem resistant Klebsiella pneumoniae in water by UV-C, UV-C/persulfate and UV-C/H2O2. Evaluation of response to antibiotic, residual effect of the processes and removal of resistance gene. J. Environ. Chem. Eng. 2018;8(1) doi: 10.1016/j.jece.2018.02.004. [DOI] [Google Scholar]
  34. Bounty S., Rodriguez R.A., Linden K.G. Inactivation of adenovirus using low-doseUV/H2O2 advanced oxidation. Water Res. 2012;46(19):6273–6278. doi: 10.1016/j.watres.2012.08.036. [DOI] [PubMed] [Google Scholar]
  35. Grossman J., Pierce A., Mody J., Gagne J., Sykora C., Sayood S., Cook S., Shomer N., Liang S.Y., Eckhouse S. Institution of a novel process for N95 respirator disinfection with vaporized hydrogen peroxide in the setting of the COVID-19 pandemic at a large academic medical center. J. Am. Coll. Surg. 2020;231(2):275–280. doi: 10.1016/j.jamcollsurg.2020.04.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Tseng C.C., Li C.S. Inactivation of viruses on surfaces by ultraviolet germicidal irradiation. J. Occup. Environ. Hyg. 2007;4(6):400–405. doi: 10.1080/15459620701329012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Linley E., Denyer S.P., McDonnell G., Simons C., Maillard J.Y. Use of hydrogen peroxide as a biocide: new consideration of its mechanisms of biocidal action. J. Antimicrob. Chemother. 2012;67(7):1589–1596. doi: 10.1093/jac/dks129. [DOI] [PubMed] [Google Scholar]
  38. Hogg N., Zielonka J., Kalyanaraman B. Detection of nitric oxide and peroxynitrite in biological systems: a state-of-the-art review. Nitric Oxide. 2017:23–44. doi: 10.1016/b978-0-12-804273-1.00003-x. [DOI] [Google Scholar]
  39. Trujillo M., Alvarez B., Souza J.M., Romero N., Castro L., Thomson L., Radi R. Mechanisms and biological consequences of peroxynitrite-dependent protein oxidation and nitration. Nitric Oxide. 2010:61–102. doi: 10.1016/b978-0-12-373866-0.00003-4. [DOI] [Google Scholar]
  40. Fichet G., Antloga K., Comoy E., Deslys J.P., McDonnell G. Prion inactivation using a new gaseous hydrogen peroxide sterilisation process. J. Hosp. Infect. 2007;67(3):278–286. doi: 10.1016/j.jhin.2007.08.020. [DOI] [PubMed] [Google Scholar]
  41. McDonnell G. The use of hydrogen peroxide for disinfection and sterilization applications. PATAI'S Chem. Funct. Groups. 2009:1–34. doi: 10.1002/9780470682531.pat0885. [DOI] [Google Scholar]
  42. Chang J.C., Ossoff S.F., Lobe D.C., Dorfman M.H., Dumais C.M., Qualls R.G., Johnson J.D. UV inactivation of pathogenic and indicator microorganisms. Appl. Environ. Microbial. 1985;49(6):1361–1365. doi: 10.1016/j.jhin.2007.08.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Goyal S.M., Chander Y., Yezli S., Otter J. Evaluating the virucidal efficacy of hydrogen peroxide vapour. J. Hosp. Infect. 2014;86:255–259. doi: 10.1016/j.jhin.2014.02.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Torres A.E., Lyons A.B., Narla S., Kohli I., Parks-Miller A., Ozog D., Hamzavi I.H., Lim H.W. Ultraviolet-C and other methods of decontamination of filtering facepiece N-95 respirators during the COVID-19 pandemic. Photochem. Photobiol. Sci. 2020;19:746–751. doi: 10.1039/d0pp00131g. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Duan S.M., Zhao X.S., Wen R.F., Huang J.J., Pi G.H., Zhang S.X., Han J., Bi S.L., Ruan L., Dong X.P. SARS Research Team. Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. Biomed. Environ. Sci. 2003;16(3):246–255. PMID: 14631830. [PubMed] [Google Scholar]
  46. Darnell M.E., Subbarao K., Feinstone S.M., Taylor D.R. Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. J. Virol. Methods. 2004;121(1):85–91. doi: 10.1016/j.jviromet.2004.06.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Saknimit M., Inatsuki I., Sugiyama Y., Yagami K. Virucidal efficacy of physicochemical treatments against coronaviruses and parvoviruses of laboratory animals. Jikken Dobutsu. 1988;37(3):341–345. doi: 10.1538/expanim1978.37.3_341. doi: 10.1538/expanim1978.37.3_341. [DOI] [PubMed] [Google Scholar]
  48. Zhou P., Yang X., Wang X.G., Hu B., Zhang L., Zhang W., Sui H.R., Y Z., Li B., Huang C.L., Chen H.D., Chen J., Luo Y., Guo H., Jiang R.D., Liu M.Q., Chen Y., Shen X.R., Wang X., Zheng X.S., Zhao K., Chen Q.J., Deng F., Liu L.L, Yan B. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. doi: 10.1038/s41586-020-2012-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Kowalski W.J, Walsh T.J., Petraitis V. COVID-19 coronavirus ultraviolet susceptibility. Purplesun. 2020 doi: 10.13140/RG.2.2.22803.22566. [DOI] [Google Scholar]
  50. Lowe J.J., Paladino K.D., Farke J.D., Boutler K., Cawcutt K., Emodi M., Gibbs S., Hankins R., Hinkle L., Micheels T., Schwedhelm S., Vasa A., Wadman M., Watson S., Rupp M.E. N95 Filtering facepiece respirator ultraviolet germicidal irradiation (UVGI) process for decontamination and reuse. Neb. Med. 2020 https://www.nebraskamed.com/sites/default/files/documents/covid-19/n-95-decon-process.pdf [Google Scholar]
  51. Liao L., Xiao W., Zhao M., Yu X., Wang H., Wang Q., Chu S., Cui Y. Can N95 respirators be reused after disinfection? How many times? ACS Nano. 2020;14(5):6348–6356. doi: 10.1021/acsnano.0c03597. [DOI] [PubMed] [Google Scholar]
  52. NIOSH Determination of particulate filter efficiency level for N95 series filters against solid particulates for non-powdered. Air Purif. Respir. Stand. Test. Proced. (STP) 2020 https://www.cdc.gov/niosh/npptl/stps/pdfs/TEB-APR-STP-0059-508.pdf NIOSH-approved FFRs (https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#2019-ncov) [Google Scholar]
  53. Peters A., Palomo R., Ney H., et al. The COVID-19 pandemic and N95 masks: reusability and decontamination methods. Antimicrob. Resist. Infect. Control. 2021;10:83. doi: 10.1186/s13756-021-00921-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Fisher E.M., Williams J.L., Shaffer R.E. Evaluation of microwave steam bags for the decontamination of filtering facepiece respirators. PloS one. 2011;6(4):e18585. doi: 10.1371/journal.pone.0018585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Lore M.B., Heimbuch B.K., Brown T.L., Wander J.D., Hinrichs S.H. Effectiveness of three decontamination treatments against influenza virus applied to filtering facepiece respirators. Ann. Occup. Hyg. 2012;56(1):92–101. doi: 10.1093/annhyg/mer054. [DOI] [PubMed] [Google Scholar]
  56. Viscusi D.J., Bergman M.S., Novak D.A., Faulkner K.A., Palmiero A., Powell J., Shaffer R.E. Impact of three biological decontamination methods on filtering facepiece respirator fit, odor, comfort, and donning ease. J. Occup. Environ. Hyg. 2011;8(7):426–436. doi: 10.1080/15459624.2011.58592.7. [DOI] [PubMed] [Google Scholar]
  57. Mills D., Harnish D.A., Lawrence C., Sandoval-Powers M., Heimbuch B.K. Ultraviolet germicidal irradiation of influenza-contaminated N95 filtering facepiece respirators. Am J. Infect. Control. 2018;46(7):49–55. doi: 10.1016/j.ajic.2018.02.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Lin T.H., Chen C.C., Huang S.H., Kuo C.W., Lai C.Y., Lin W.Y. Filter quality of electret masks in filtering 14.6-594 nm aerosol particles: effects of five decontamination methods. PloS one. 2017;12(10) doi: 10.1371/journal.pone.0186217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Salter W.B., Kinney K., Wallace W.H., Lumley A.E., Heimbuch B.K., Wander J.D. Analysis of residual chemicals on filtering facepiece respirators after decontamination. J. Occup. Environ. Hyg. 2010;7(8):437–445. doi: 10.1080/15459624.2010.484794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. NIOSH, 2019. Determination of particulate filter efficiency level for N95 series filters against solid particulates for non-powdered air purifying respirators standard test procedure (STP). NIOSH STP, Dec 2019 (Procedure no. TEB-APR-STP-0059, Revision: 3.2), 19. https://www.cdc.gov/niosh/npptl/stps/pdfs/TEB-APR-STP-0059-508.pdf

Articles from Environmental Challenges (Amsterdam, Netherlands) are provided here courtesy of Elsevier

RESOURCES